Company intelligence / Profile preview

PatchClamp Medtech

Seattle, Washington, United States

Ownership: Private
Development stage: Other

Overview

PatchClamp Medtech's device for minimally invasive watertight dural closure has completed preclinical proof-of-concept, demonstrated successful laboratory sealing of dura models, and entered ongoing in vivo (animal) testing supported by NIH SBIR grant funding. No human clinical studies or commercial availability as of late 2025.

Therapeutic areas: Neurology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Product Creation Studio (engineering, product design, and prototyping partner)

Beyond the preview

Go deeper on PatchClamp Medtech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PatchClamp Medtech.

Explore the full profile